Regenxbio (RGNX) came out with a quarterly loss of $1.2 per share versus the Zacks Consensus Estimate of a loss of$1.38. This compares to a loss of $1.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +13.04$1.13 per share when it actually produced a loss of $1.38, delivering a surprise of -22.12%.Over the last four quarters, the company h ...